Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-008359
Filing Date
2025-05-02
Accepted
2025-05-02 16:26:11
Documents
1
Period of Report
2025-04-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2426
  Complete submission text file 0001641172-25-008359.txt   4254
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address L-3-E-8, ENTERPRISE 4 TAMAN TEKNOLOGI MRANTI BUKIT JALIL KUALA LUMPUR N8 57000
Business Address L-3-E-8, ENTERPRISE 4 TAMAN TEKNOLOGI MRANTI BUKIT JALIL KUALA LUMPUR N8 57000 6012-2237897
SURIA SUKSES ENGINEERING SDN BHD (Reporting) CIK: 0002044793 (see all company filings)

State of Incorp.: N8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25908972